Karen S. Kelly‐Spratt

3.2k citations
24 papers · 2.0k indexed · 1 hit paper · h-index 17
Topics
Advanced Proteomics Techniques and Applications (7 papers)Cancer-related Molecular Pathways (6 papers)Glycosylation and Glycoproteins Research (5 papers)

In The Last Decade

Karen S. Kelly‐Spratt

24 papers receiving 2.0k citations

Hit Papers

Intent-to-treat leukemia remission by CD19 CAR T cells of...20172026202020232017250500750

Peers

Karen S. Kelly‐Spratt
Comparison fields: 5 of 96
  • Oncology 1.3k
  • Molecular Biology 1.0k
  • Spectroscopy 356
  • Genetics 318
  • Biomedical Engineering 297
Replace Mingang Hao with:
Mingang Hao China
Christopher J. Tape United Kingdom
Jeffrey A. Magee United States
Leticia Oliveira‐Ferrer Germany
Aïcha Demidem France
Dana A. M. Mustafa Netherlands
Surajit Dhara United States
Sanaz Memarzadeh United States
Gregory K. Behbehani United States
Kam Sprott United States
Karen S. Kelly‐Spratt relative to Mingang Hao China Mingang Hao's profile →
Citations per field
00.5×6.1×
Mingang Hao · 1×
Citations per year

Countries citing papers authored by Karen S. Kelly‐Spratt

Since Specialization
Citations

This map shows the geographic impact of Karen S. Kelly‐Spratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen S. Kelly‐Spratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen S. Kelly‐Spratt more than expected).

Fields of papers citing papers by Karen S. Kelly‐Spratt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen S. Kelly‐Spratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen S. Kelly‐Spratt. The network helps show where Karen S. Kelly‐Spratt may publish in the future.

Co-authorship network of co-authors of Karen S. Kelly‐Spratt

This figure shows the co-authorship network connecting the top 25 collaborators of Karen S. Kelly‐Spratt. A scholar is included among the top collaborators of Karen S. Kelly‐Spratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen S. Kelly‐Spratt. Karen S. Kelly‐Spratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 130
2 16
3 7
4 13
5 120
6 35
7 69
8 33
9 37
10 14
11 11
12 19
13 49
14 41
15 174
16 69
17 175
18 18
19
A TrkB/insulin receptor-related receptor chimeric receptor induces PC12 cell differentiation and exhibits prolonged activation of mitogen-activated protein kinase.
20
20 26

About Karen S. Kelly‐Spratt

Karen S. Kelly‐Spratt is a scholar working on Oncology, Spectroscopy and Biotechnology, having authored 24 papers that have together received 2.0k indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (7 papers), Cancer-related Molecular Pathways (6 papers) and Glycosylation and Glycoproteins Research (5 papers). The work is most often cited by research in Oncology (1.3k citations), Spectroscopy (356 citations) and Molecular Biology (1.0k citations). Karen S. Kelly‐Spratt has collaborated with scholars based in United States, Switzerland and South Africa. Frequent co-authors include Christopher J. Kemp, Virginia J. Hoglund, Michael C. Jensen, Olivia Finney, Stephanie Mgebroff, Rebecca Gardner, Catherine Lindgren, Christopher Brown, Julie R. Park and Assaf P. Oron. Their work appears in journals such as Genes & Development, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026